BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29972412)

  • 1. Adropin and Irisin in Patients with Cardiac Cachexia.
    Kalkan AK; Cakmak HA; Erturk M; Kalkan KE; Uzun F; Tasbulak O; Diker VO; Aydin S; Celik A
    Arq Bras Cardiol; 2018 Jul; 111(1):39-47. PubMed ID: 29972412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adropin and irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and peritoneal dialysis.
    Kałużna M; Hoppe K; Schwermer K; Ibrahim AY; Pawlaczyk K; Ziemnicka K
    Pol Arch Med Wewn; 2016 Jul; 126(7-8):474-82. PubMed ID: 27452672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of adropin in heart failure patients.
    Lian W; Gu X; Qin Y; Zheng X
    Intern Med; 2011; 50(15):1523-7. PubMed ID: 21804276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adropin and irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study.
    Kałużna M; Pawlaczyk K; Schwermer K; Hoppe K; Człapka-Matyasik M; Ibrahim AY; Sawicka-Gutaj N; Minczykowski A; Ziemnicka K; Oko A; Ruchała M
    Adv Clin Exp Med; 2019 Mar; 28(3):347-353. PubMed ID: 30525316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.
    Murdoch DR; Rooney E; Dargie HJ; Shapiro D; Morton JJ; McMurray JJ
    Heart; 1999 Sep; 82(3):352-6. PubMed ID: 10455089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of serum and cardiac tissue adropin, copeptin, irisin and TRPM2 expressions in DOX treated male rats.
    Aydin S; Eren MN; Kuloglu T; Aydin S; Yilmaz M; Gul E; Kalayci M; Yel Y; Cakmak T; Bico S
    Biotech Histochem; 2015 Apr; 90(3):197-205. PubMed ID: 25434395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between adiponectin, NT-pro-BNP and left ventricular ejection fraction in non-cachectic patients with systolic heart failure: an observational study.
    Tengiz İ; Türk UÖ; Alioğlu E; Kırılmaz B; Tamer GS; Tüzün N; Ercan E
    Anadolu Kardiyol Derg; 2013 May; 13(3):221-6. PubMed ID: 23376650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac cachexia is associated with right ventricular failure and liver dysfunction.
    Valentova M; von Haehling S; Krause C; Ebner N; Steinbeck L; Cramer L; Doehner W; Murin J; Anker SD; Sandek A
    Int J Cardiol; 2013 Nov; 169(3):219-24. PubMed ID: 24063924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
    Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
    Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus.
    Aydin S; Kuloglu T; Aydin S
    Peptides; 2013 Sep; 47():66-70. PubMed ID: 23850897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irisin, adropin, and preptin as biomarkers of energy dysregulation in depressive disorder.
    Cicek MA; Tuygar Okutucu F; Ozturk N
    Curr Med Res Opin; 2023 Sep; 39(9):1263-1270. PubMed ID: 37574912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Valsartan and Amlodipine on the Levels of Irisin, Adropin, and Perilipin.
    Çelik HT; Akkaya N; Erdamar H; Gok S; Kazanci F; Demircelik B; Cakmak M; Yigitoglu R
    Clin Lab; 2015; 61(12):1889-95. PubMed ID: 26882812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.
    Maciorkowska M; Musiałowska D; Małyszko J
    Adv Clin Exp Med; 2019 Nov; 28(11):1571-1575. PubMed ID: 31756066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
    Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.
    Ponikowski P; Piepoli M; Chua TP; Banasiak W; Francis D; Anker SD; Coats AJ
    Eur Heart J; 1999 Nov; 20(22):1667-75. PubMed ID: 10543930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the irisin, preptin and adropin levels in the blood serum of Alburnus tarichi.
    Caf F; Algul S; Koyun M
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):95-99. PubMed ID: 28886320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.
    Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P
    Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study.
    Silvestrini A; Bruno C; Vergani E; Venuti A; Favuzzi AMR; Guidi F; Nicolotti N; Meucci E; Mordente A; Mancini A
    PLoS One; 2019; 14(1):e0210320. PubMed ID: 30657767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum irisin level in myocardial infarction patients with or without heart failure.
    Abd El-Mottaleb NA; Galal HM; El Maghraby KM; Gadallah AI
    Can J Physiol Pharmacol; 2019 Oct; 97(10):932-938. PubMed ID: 30958967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.